Literature DB >> 33477393

Microstructured Lipid Carriers (MLC) Based on N-Acetylcysteine and Chitosan Preventing Pseudomonas aeruginosa Biofilm.

Marta Guerini1, Pietro Grisoli1, Cristina Pane1, Paola Perugini1.   

Abstract

The aim of this work was the development of microstructured lipid carriers (MLC) based on chitosan (CH) and containing N-acetylcysteine (NAC), a mucolytic and antioxidant agent, to inhibit the formation of Pseudomonas aeruginosa biofilm. MLC were prepared using the high shear homogenization technique. The MLC were characterized for morphology, particle size, Z potential, encapsulation efficiency and drug release. The antioxidant properties of NAC-loaded microstructured carriers were evaluated through an in vitro spectrophotometer assay. Finally, the activity of NAC-CH-MLC on biofilm production by Pseudomonas aeruginosa was also evaluated. Results obtained from this study highlighted that the use of chitosan into the inner aqueous phase permitted to obtain microstructured particles with a narrow size range and with good encapsulation efficiency. NAC-loaded MLC showed higher antioxidant activity than the free molecule, demonstrating how encapsulation increases the antioxidant effect of the molecule. Furthermore, the reduction of biofilm growth resulted extremely high with MLC being 64.74% ± 6.2% and 83.74% ± 9.95%, respectively, at 0.5 mg/mL and 2 mg/mL. In conclusion, this work represents a favorable technological strategy against diseases in which bacterial biofilm is relevant, such as cystic fibrosis.

Entities:  

Keywords:  N-acetylcysteine; Pseudomonas aeruginosa; antioxidant activity; biofilm; chitosan; cystic fibrosis; microstructured lipid carriers

Mesh:

Substances:

Year:  2021        PMID: 33477393      PMCID: PMC7830306          DOI: 10.3390/ijms22020891

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  49 in total

Review 1.  N-acetylcysteine: pharmacological considerations and experimental and clinical applications.

Authors:  I A Cotgreave
Journal:  Adv Pharmacol       Date:  1997

2.  Development and characterization of new and scalable topical formulations containing N-acetyl-d-glucosamine-loaded solid lipid nanoparticles.

Authors:  Joana Marto; Cecilia Sangalli; Priscilla Capra; Paola Perugini; Andreia Ascenso; Lídia Gonçalves; Helena Ribeiro
Journal:  Drug Dev Ind Pharm       Date:  2017-06-21       Impact factor: 3.225

3.  Enhanced Pseudomonas aeruginosa biofilm development mediated by human neutrophils.

Authors:  Travis S Walker; Kerry L Tomlin; G Scott Worthen; Katie R Poch; Jonathan G Lieber; Milene T Saavedra; Michael B Fessler; Kenneth C Malcolm; Michael L Vasil; Jerry A Nick
Journal:  Infect Immun       Date:  2005-06       Impact factor: 3.441

4.  Antioxidant activity and partitioning of phenolic acids in bulk and emulsified methyl linoleate.

Authors:  S S Pekkarinen; H Stöckmann; K Schwarz; I M Heinonen; A I Hopia
Journal:  J Agric Food Chem       Date:  1999-08       Impact factor: 5.279

5.  Chitosan disrupts the barrier properties of the outer membrane of gram-negative bacteria.

Authors:  I M Helander; E L Nurmiaho-Lassila; R Ahvenainen; J Rhoades; S Roller
Journal:  Int J Food Microbiol       Date:  2001-12-30       Impact factor: 5.277

Review 6.  Hyperacidification in cystic fibrosis: links with lung disease and new prospects for treatment.

Authors:  Jens Poschet; Elizabeth Perkett; Vojo Deretic
Journal:  Trends Mol Med       Date:  2002-11       Impact factor: 11.951

Review 7.  CFTR structure and cystic fibrosis.

Authors:  Natasha Cant; Naomi Pollock; Robert C Ford
Journal:  Int J Biochem Cell Biol       Date:  2014-02-15       Impact factor: 5.085

8.  Anti-biofilm effects of anthranilate on a broad range of bacteria.

Authors:  Xi-Hui Li; Soo-Kyoung Kim; Joon-Hee Lee
Journal:  Sci Rep       Date:  2017-08-17       Impact factor: 4.379

9.  Allele specific repair of splicing mutations in cystic fibrosis through AsCas12a genome editing.

Authors:  Giulia Maule; Antonio Casini; Claudia Montagna; Anabela S Ramalho; Kris De Boeck; Zeger Debyser; Marianne S Carlon; Gianluca Petris; Anna Cereseto
Journal:  Nat Commun       Date:  2019-08-07       Impact factor: 14.919

10.  Association among serum and salivary A. actinomycetemcomitans specific immunoglobulin antibodies and periodontitis.

Authors:  Gaetano Isola; Alessandro Polizzi; Romeo Patini; Sebastiano Ferlito; Angela Alibrandi; Giuseppe Palazzo
Journal:  BMC Oral Health       Date:  2020-10-15       Impact factor: 2.757

View more
  2 in total

Review 1.  N-acetylcysteine (NAC) and Its Role in Clinical Practice Management of Cystic Fibrosis (CF): A Review.

Authors:  Marta Guerini; Giorgia Condrò; Valeria Friuli; Lauretta Maggi; Paola Perugini
Journal:  Pharmaceuticals (Basel)       Date:  2022-02-11

2.  Evaluation of the Mucoadhesive Properties of Chitosan-Based Microstructured Lipid Carrier (CH-MLC).

Authors:  Marta Guerini; Giorgia Condrò; Paola Perugini
Journal:  Pharmaceutics       Date:  2022-01-12       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.